Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on Celestica, Raises Price Target to $38

Author: Benzinga Newsdesk | January 31, 2024 11:24am
RBC Capital analyst Maxim Matushansky maintains Celestica (NYSE:CLS) with a Outperform and raises the price target from $33 to $38.

Posted In: CLS TSX:CLS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist